Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Reticulon 4 interacting protein 1 pseudogene 1 (RTN4IP1P1) is a pseudogene and not a protein-coding gene or functional receptor, enzyme, transporter, or similar molecular target. Pseudogenes are segments of DNA that resemble functional genes but typically lack the ability to encode functional proteins. RTN4IP1P1 is related to the protein-coding gene RTN4IP1, which encodes a mitochondrial NAD(P)H oxidoreductase involved in mitochondrial complex I assembly and coenzyme Q metabolism, as well as inhibition of neurite outgrowth. The pseudogene RTN4IP1P1 itself has no documented protein product, no known biological or disease roles, and is not a therapeutic target. RTN4IP1P1 refers specifically to the pseudogene on chromosome 12. All described functions and disease associations in referenced sources pertain to the protein-coding RTN4IP1 gene, not the pseudogene. Therefore, RTN4IP1P1 is not considered a therapeutic target, nor does it have directly attributed drug interactions, molecular functions, or disease associations.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Reticulon 4 interacting protein 1 pseudogene 1 (RTN4IP1P1).